BICYCLE THERAPEUTICS ANNOUNCES BROAD PARTNERSHIP WITH ASTRAZENECA TO DEVELOP BICYCLIC PEPTIDES (BICYCLES®)

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today that it has entered into a collaboration with AstraZeneca for the identification and development of bicyclic peptides (Bicycles®) for the treatment of respiratory, cardiovascular and metabolic diseases. Read More